1 |
Evaluation of Outcomes Following Hospital-Wide Implementation of a Subcutaneous Insulin Protocol for Diabetic Ketoacidosis |
|
|
| Priya Rao, Sheng-fang Jiang, Patricia Kipnis, Divyesh M. Patel, Svetlana Katsnelson, Samineh Madani, Vincent X. Liu |
|
| JAMA Network Open. 2022; 5(4): e226417 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Acidose métabolique |
|
|
| Audrey De Jong, Joris Pensier, Boris Jung, Fouad Belafia, Gérald Chanques, Samir Jaber |
|
| Anesthésie & Réanimation. 2021; 7(1): 35 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Subcutaneous Rapid-acting Insulin Analogs for Diabetic Ketoacidosis |
|
|
| Lillian Chow, Walter Valesky, Shahriar Zehtabchi |
|
| Academic Emergency Medicine. 2021; 28(6): 700 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Outcomes of diabetic ketoacidosis in a tertiary centre with restricted
intensive care unit
bed capacity
|
|
|
| Iftach Sagy, Noa Zimhony-Nissim, Evgenia Brandstaetter, Inna Lipnitzki, Hadeel Musa, Yakov Rosen, Leonid Barski |
|
| Internal Medicine Journal. 2021; 51(6): 948 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Use of a Flexible Catheter for the Administration of Subcutaneous Insulin in Diabetic Ketoacidosis: A Feasibility Controlled Clinical Trial |
|
|
| Maria Laura Beaudoin, Milagros Torrents, María Florencia Tittarelli, Magali Hamui, Mariano Ibarra, Mabel Ferraro, Juan Pablo Ferreira |
|
| Hospital Pediatrics. 2021; 11(4): 396 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Diabetic ketoacidosis |
|
|
| Ketan K. Dhatariya, Nicole S. Glaser, Ethel Codner, Guillermo E. Umpierrez |
|
| Nature Reviews Disease Primers. 2020; 6(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway |
|
|
| Karli Edholm, Katie Lappé, Polina Kukhareva, Christy Hopkins, Nathan D. Hatton, Benjamin Gebhart, Heather Nyman, Emily Signor, Mikyla Davis, Kensaku Kawamoto, Stacy A. Johnson |
|
| Journal for Healthcare Quality. 2020; 42(5): e66 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations |
|
|
| Nadine E Palermo, Archana R Sadhu, Marie E McDonnell |
|
| The Journal of Clinical Endocrinology & Metabolism. 2020; 105(8): 2819 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of
COVID
-19 and resource-limited settings-role of subcutaneous insulin
|
|
|
| Leena Priyambada, Joseph I. Wolfsdorf, Stuart J. Brink, Maria Fritsch, Ethel Codner, Kim C. Donaghue, Maria E. Craig |
|
| Pediatric Diabetes. 2020; 21(8): 1394 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison |
|
|
| Kota Vidyasagar, Boya Chandrasekar, Manik Chhabra, Anil Bhansali, Dipika Bansal |
|
| Clinical Therapeutics. 2020; 42(8): e115 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis |
|
|
| Carlos A Andrade-Castellanos, Luis Enrique Colunga-Lozano, Netzahualpilli Delgado-Figueroa, Daniel A Gonzalez-Padilla |
|
| Cochrane Database of Systematic Reviews. 2016; 2016(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Question 1: Treatment of mild to moderate ketoacidosis in children and adolescents with subcutaneous insulin |
|
|
| D. Mul,E. Molendijk |
|
| Archives of Disease in Childhood. 2015; 100(1): 106 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Evaluation of Ward Management of Diabetic Ketoacidosis |
|
|
| Branden D. Nemecek, Kathie L. Hermayer, Pamela C. Arnold, Nicole M. Bohm |
|
| Clinical Diabetes. 2014; 32(3): 100 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: A review of the current evidence from clinical studies |
|
|
| M. Vincent,E. Nobécourt |
|
| Diabetes & Metabolism. 2013; 39(4): 299 |
|
| [Pubmed] [Google Scholar] [DOI] |
|